← Eichor
Condition: Primary Progressive Aphasia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Primary Progressive Aphasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Speech and Language Interventions for Italian People With PPA
Phase N/A · 2 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT06739967Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment
NA · 1 location(s) · Tianjin Huanhu Hospital · NCT07643363Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders
Phase N/A · 1 location(s) · Nantes University Hospital · NCT06059313Longitudinal Cognitive Assessment by BoCA
Phase N/A · 1 location(s) · Alzheimer's Light LLC · NCT04114994Genetic Frontotemporal Dementia Initiative for Neurodevelopment
Phase N/A · 1 location(s) · Western University · NCT05779813Amyotrophic Lateral Sclerosis (ALS) Families Project
Phase N/A · 1 location(s) · Columbia University · NCT03865420Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05020626Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Long Term Effect of Brain Stimulation in PPA
NA · 1 location(s) · Hospital San Carlos, Madrid · NCT07158216Tau PET/CT in Various Tau-Related Disease Patients
Phase N/A · 2 location(s) · Tianjin Medical University · NCT06690983Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125ALS Research Collaborative
Phase N/A · 1 location(s) · ALS Therapy Development Institute · NCT06885918Social & Affective Cognition in Alzheimer's Disease & Associated Disorders
NA · 1 location(s) · University Hospital, Lille · NCT06338397Language in Primary Progressive Aphasia
Phase N/A · 1 location(s) · Northwestern University · NCT00537004Cerebro Spinal Fluid Collection (CSF)
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT04844060Remotely-supervised Neuromodulation in PPA
NA · 2 location(s) · Maya Henry · NCT07260253UPenn Observational Research Repository on Neurodegenerative Disease
Phase N/A · 1 location(s) · University of Pennsylvania · NCT04715399Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT05588167Nabilone for Agitation in Frontotemporal Dementia
Phase 2 · 7 location(s) · Simon Ducharme, MD · NCT05742698A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niem
Phase 3 · 35 location(s) · Azafaros B.V. · NCT07082725Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT03225144Memory and Social Interactions
Phase N/A · 1 location(s) · University Hospital, Caen · NCT05800028The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
Phase N/A · 1 location(s) · Mayo Clinic · NCT03313011Enhancing Language Function in Aphasia
NA · 1 location(s) · University of Arizona · NCT05443633ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04865172Modifiable Variables in Parkinsonism (MVP)
Phase N/A · 1 location(s) · Bastyr University · NCT02194816The Swedish BioFINDER 2 Study
NA · 2 location(s) · Skane University Hospital · NCT03174938Intervention for Communication Quality of Life in Primary Progressive Aphasia
NA · 1 location(s) · Maya Henry · NCT07219680A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pi
Phase 2 · 3 location(s) · Azafaros B.V. · NCT07399704Comprehensive Assessment of Neurodegeneration and Dementia
Phase N/A · 19 location(s) · McGill University · NCT03402919
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.